Yu M, Long Y, Yang Y, Li M, Teo T, Noll B, Philip S, Wang S. Discovery of a potent, highly selective, and orally bioavailable inhibitor of CDK8 through a structure-based optimisation. Eur J Med Chem 2021;218:113391. [PMID: 33823391 DOI: 10.1016/j.ejmech.2021.113391][Reference Citation Analysis]
3
Yan Y, Xing C, Xiao Y, Shen X, Zhang Z, He C, Shi JB, Liu M, Liu X. Discovery and Anti-Inflammatory Activity Evaluation of a Novel CDK8 Inhibitor through Upregulation of IL-10 for the Treatment of Inflammatory Bowel Disease In Vivo. J Med Chem 2022. [PMID: 35536548 DOI: 10.1021/acs.jmedchem.2c00356][Reference Citation Analysis]